Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Genetic polymorphisms at TIMP3 are associated with survival of adenocarcinoma of the gastroesophageal junction.

Bashash M, Shah A, Hislop G, Treml M, Bretherick K, Janoo-Gilani R, Leach S, Le N, Bajdik C, Brooks-Wilson A.

PLoS One. 2013;8(3):e59157. doi: 10.1371/journal.pone.0059157. Epub 2013 Mar 19.

2.

DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.

Ott K, Rachakonda PS, Panzram B, Keller G, Lordick F, Becker K, Langer R, Buechler M, Hemminki K, Kumar R.

Ann Surg Oncol. 2011 Sep;18(9):2688-98. doi: 10.1245/s10434-011-1601-y. Epub 2011 Feb 24.

PMID:
21347786
3.

Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction.

Wang WP, Wang KN, Gao Q, Chen LQ.

World J Surg Oncol. 2012 Jan 17;10:14. doi: 10.1186/1477-7819-10-14.

4.

Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy.

Cardona K, Zhou Q, Gönen M, Shah MA, Strong VE, Brennan MF, Coit DG.

Ann Surg Oncol. 2013 Feb;20(2):548-54. doi: 10.1245/s10434-012-2598-6. Epub 2012 Sep 1.

PMID:
22941159
5.

Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction.

Barbour AP, Rizk NP, Gerdes H, Bains MS, Rusch VW, Brennan MF, Coit DG.

J Am Coll Surg. 2007 Oct;205(4):593-601. Epub 2007 Jul 20.

PMID:
17903735
6.

The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma.

Demicco EG, Farris AB 3rd, Baba Y, Agbor-Etang B, Bergethon K, Mandal R, Daives D, Fukuoka J, Shimizu M, Dias-Santagata D, Ogino S, Iafrate AJ, Gaissert HA, Mino-Kenudson M.

Mod Pathol. 2011 Sep;24(9):1177-90. doi: 10.1038/modpathol.2011.77. Epub 2011 May 13.

7.

Comparison of gastro-oesophageal junction carcinomas in Chinese versus American patients.

Huang Q, Fan X, Agoston AT, Feng A, Yu H, Lauwers G, Zhang L, Odze RD.

Histopathology. 2011 Aug;59(2):188-97. doi: 10.1111/j.1365-2559.2011.03924.x.

PMID:
21884197
8.

Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer.

Talsma K, van Hagen P, Grotenhuis BA, Steyerberg EW, Tilanus HW, van Lanschot JJ, Wijnhoven BP.

Ann Surg Oncol. 2012 Jul;19(7):2142-8. doi: 10.1245/s10434-012-2218-5. Epub 2012 Mar 7.

9.
10.

Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma.

Hjortland GO, Meza-Zepeda LA, Beiske K, Ree AH, Tveito S, Hoifodt H, Bohler PJ, Hole KH, Myklebost O, Fodstad O, Smeland S, Hovig E.

BMC Cancer. 2011 Oct 20;11:455. doi: 10.1186/1471-2407-11-455.

11.

Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.

Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, Coit DG, Brennan MF.

Ann Surg Oncol. 2007 Feb;14(2):306-16. Epub 2006 Nov 8.

PMID:
17091329
12.

Array comparative genomic hybridization, expression array, and protein analysis of critical regions on chromosome arms 1q, 7q, and 8p in adenocarcinomas of the gastroesophageal junction.

van Dekken H, Tilanus HW, Hop WC, Dinjens WN, Wink JC, Vissers KJ, van Marion R.

Cancer Genet Cytogenet. 2009 Feb;189(1):37-42. doi: 10.1016/j.cancergencyto.2008.08.018.

PMID:
19167610
13.

High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas.

van Duin M, van Marion R, Vissers KJ, Hop WC, Dinjens WN, Tilanus HW, Siersema PD, van Dekken H.

Cytogenet Genome Res. 2007;118(2-4):130-7.

PMID:
18000363
14.

Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer.

Reim D, Gertler R, Novotny A, Becker K, zum Büschenfelde CM, Ebert M, Dobritz M, Langer R, Hoefler H, Friess H, Schumacher C.

Ann Surg Oncol. 2012 Jul;19(7):2108-18. doi: 10.1245/s10434-011-2147-8. Epub 2011 Dec 1.

PMID:
22130620
15.

CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma.

Stocker G, Ott K, Henningsen N, Becker K, Hapfelmeier A, Lordick F, Hois S, Plaschke S, Höfler H, Keller G.

Eur J Cancer. 2009 Dec;45(18):3326-35. doi: 10.1016/j.ejca.2009.09.021. Epub 2009 Oct 12.

PMID:
19822419
16.

[Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].

Pedrazzani C, Pasini F, Giacopuzzi S, Bernini M, Ruzzenente A, Festini M, Tomasi I, Cristadoro L, de Manzoni G.

G Chir. 2004 Oct;25(10):325-33. Italian.

PMID:
15756954
17.

Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.

Hosokawa Y, Kinoshita T, Konishi M, Takahashi S, Gotohda N, Kato Y, Daiko H, Nishimura M, Katsumata K, Sugiyama Y, Kinoshita T.

Ann Surg Oncol. 2012 Feb;19(2):677-83. doi: 10.1245/s10434-011-1983-x. Epub 2011 Aug 6.

PMID:
21822549
18.

Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression.

Lei H, Hemminki K, Altieri A, Johansson R, Enquist K, Hallmans G, Lenner P, Försti A.

Breast Cancer Res Treat. 2007 May;103(1):61-9. Epub 2006 Oct 11.

PMID:
17033924
19.

Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.

Zhang X, Watson DI, Jamieson GG.

Chin Med J (Engl). 2007 Dec 20;120(24):2268-70.

PMID:
18167216
20.

Predicting individual survival after potentially curative esophagectomy for adenocarcinoma of the esophagus or gastroesophageal junction.

Lagarde SM, Reitsma JB, Ten Kate FJ, Busch OR, Obertop H, Zwinderman AH, Moons J, van Lanschot JJ, Lerut T.

Ann Surg. 2008 Dec;248(6):1006-13. doi: 10.1097/SLA.0b013e318190a0a2.

PMID:
19092345

Supplemental Content

Support Center